Fundz

Diakonos Oncology raised $11.4M in a seed round led by Restem Group Inc. to advance its dendritic cell vaccine into a Phase 2 clinical trial.

PRIVATEAug 26, 2024

Amount Raised

$11.4 Million

Round Type

Seed

HoustonBiotechnologyHealth CareMedicalTherapeutics

Investors

Restem Group Inc.

Description

Diakonos Oncology Corp. announced the final closing of an oversubscribed seed financing of $11.4 million, which will fund operations into late 2025 and support the initiation of a Phase 2 clinical trial for its lead asset, DOC1021. The round was led by Restem Group Inc. with participation from existing investors.

Company Information

Company

Diakonos Oncology

Location

Houston, Texas, United States

About

Diakonos Oncology Corp. is a clinical stage immuno-oncology company based in Houston, TX. The company is at the forefront of developing dendritic cell vaccines that leverage a patient's immune system to target and eliminate cancer cells, mimicking the body's natural response to viral infections.

Fundz sees it the moment Diakonos Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Diakonos Oncology's next move

See what Strategic adds

Diakonos Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.